Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2

EU orphan designation number: EU/3/18/2067   
Active ingredient: Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2
Indication: Treatment in haematopoietic stem cell transplantation
Sponsor: Omeros London Limited
2nd Floor, Berkeley Square House, Berkeley Square, London W1J 6BD, United Kingdom

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/08/2018 Orphan designation EMA/OD/044/18 (2018)5737 of 24/08/2018